Last reviewed · How we verify
NCT05812300
Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis
NA trial testing Freshly manufactured 35 kDa hyaluronan fragment in Periodontitis in 20 participants. Completed in 20 February 2024.
1 January 2024
Quick facts
| Lead sponsor | Dove Medical Press Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 June 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 20 February 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Freshly manufactured 35 kDa hyaluronan fragment — full drug profile →
Conditions studied
- Periodontitis — all drugs for Periodontitis →
Sponsor
Dove Medical Press Ltd — full company profile →
Who can join
Adults 18 to 60, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can reduce symptoms and signs of gingivitis or periodontitis. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05812300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Freshly manufactured 35 kDa hyaluronan fragment
Trials testing the same drug.
- NCT05809700 — Injection Therapy for Neuropathic Pain · NA · completed
- NCT05810649 — Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds · NA · completed
Other recruiting trials for Periodontitis
Currently open trials in the same condition.
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
- NCT07491848 — Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D · recruiting
- NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
- NCT07532694 — Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients · NA · recruiting
Other Dove Medical Press Ltd trials
Trials by the same sponsor.
- NCT05809700 — Injection Therapy for Neuropathic Pain · NA · completed
- NCT05765513 — HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis · NA · completed
- NCT05765526 — A Novel Electrolyzed Water Spray Treatment for the Discomfort or Itching of Patients With Scalp · NA · completed
- NCT05766930 — The Novel Electrolyzed Water Spray Treatment the Genital Itching · NA · completed
- NCT05770258 — The Novel Electrolyzed Water Spray Treatment Mild Periodontitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05812300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dove Medical Press Ltd
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05812300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing